Clinical and Molecular Epidemiology

Pre-diagnosis plasma immune markers and risk of non-Hodgkin lymphoma in two prospective cohort studies
Mara M. Epstein, Bernard Rosner, Elizabeth C. Breen, Julie L. Batista, Edward L. Giovannucci, Larry Magpantay, Jon C. Aster, Scott J. Rodig, Kimberly A. Bertrand, Francine Laden, Otoniel Martínez-Maza, Brenda M. Birmann

Haematologica Jun 2018, haematol.2017.183236; DOI: 10.3324/haematol.2017.183236
Therapy-related acute lymphoblastic leukemia has distinct clinical and cytogenetic features compared to de novo acute lymphoblastic leukemia, but outcomes are comparable in transplanted patients
Ibrahim Aldoss, Tracey Stiller, Ni-Chun Tsai, Joo Y. Song, Thai Cao, N. Achini Bandara, Amadeep Salhotra, Samer Khaled, Ahmed Aribi, Monzr M Al Malki, Matthew Mei, Haris Ali, Ricardo Spielberger, Margaret O'Donnell, David Snyder, Thomas Slavin, Ryotaro Nakamura, Anthony S. Stein, Stephen J. Forman, Guido Marcucci, Vinod Pullarkat

Haematologica Jun 2018, haematol.2018.193599; DOI: 10.3324/haematol.2018.193599
C-reactive protein and risk of venous thromboembolism: Results from a population-based case-crossover study
Gro Grimnes, Trond Isaksen, Ynse Ieuwe Gerardus Vladimir Tichelaar, Jan Brox, Sigrid Kufaas Brækkan, John-Bjarne Hansen

Haematologica Apr 2018, haematol.2017.186957; DOI: 10.3324/haematol.2017.186957
Recurrent thrombosis in patients with antiphospholipid antibodies treated with vitamin K antagonists or rivaroxaban
Ida Martinelli, Maria Abbattista, Paolo Bucciarelli, Armando Tripodi, Andrea Artoni, Francesca Gianniello, Cristina Novembrino, Flora Peyvandi

Haematologica Mar 2018, haematol.2017.185132; DOI: 10.3324/haematol.2017.185132